Business
Announcement on Obtaining FDA Approval by Subsidiary for Sodium Selenite Injection
Announcement on Obtaining FDA Approval by Subsidiary for Sodium Selenite Injection
About this update from Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. Class A
Announcement on Obtaining FDA Approval by Subsidiary for Sodium Selenite Injection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment